These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37360415)

  • 1. Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype.
    Yin X; Hu X; Tong H; You L
    Ther Adv Chronic Dis; 2023; 14():20406223231173891. PubMed ID: 37360415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and survival of hematological cancers among adults ages ≥75 years.
    Krok-Schoen JL; Fisher JL; Stephens JA; Mims A; Ayyappan S; Woyach JA; Rosko AE
    Cancer Med; 2018 Jul; 7(7):3425-3433. PubMed ID: 29654631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
    Pulte D; Gondos A; Brenner H
    Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of Patients With Second Primary Hodgkin Lymphoma.
    Budnik J; Doucette C; Milano MT; Constine LS
    Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):316-323.e2. PubMed ID: 32014390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
    Fedeli U; Barbiellini Amidei C; Han X; Jemal A
    Int J Cancer; 2024 May; 154(10):1703-1708. PubMed ID: 38335457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
    Ye X; Mahmud S; Skrabek P; Lix L; Johnston JB
    BMJ Open; 2017 Jul; 7(7):e015106. PubMed ID: 28716788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of hematologic malignancies and evolution patterns over the past 30 years.
    Zhang N; Wu J; Wang Q; Liang Y; Li X; Chen G; Ma L; Liu X; Zhou F
    Blood Cancer J; 2023 May; 13(1):82. PubMed ID: 37193689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second primary malignancies after ocular adnexal lymphoma diagnosis.
    Loya A; Ramachandran V; Ayaz T; Weng CY
    BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of hematologic malignancies does not predict intensive care unit mortality.
    Massion PB; Dive AM; Doyen C; Bulpa P; Jamart J; Bosly A; Installé E
    Crit Care Med; 2002 Oct; 30(10):2260-70. PubMed ID: 12394954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018.
    Park WJ; Park JH; Cho S; Shin MG
    Blood Res; 2021 Dec; 56(4):301-314. PubMed ID: 34880144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the survival of older patients with hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Castro FA; Brenner H
    Cancer; 2016 Jul; 122(13):2031-40. PubMed ID: 27163715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden.
    Kieri O; Marrone G; Sönnerborg A; Nowak P
    AIDS Res Hum Retroviruses; 2022 Feb; 38(2):135-142. PubMed ID: 34652958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
    Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
    Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017].
    Zhang XC; Fan L; Lu H; Qian SX; Chen LJ; Xu W; Li JY; Qu XY; Zhao XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):389-395. PubMed ID: 37096510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.